The Japanese market for antibody therapies is set to double from about ¥80 billion in 2007 to ¥170 billion in 2010

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.556, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C Heavyweights: Schering-Plough and Roche are Slugging it Out for Dominance in a Billion-dollar Market

Pharmaceutical Innovation, Vol. 11, Iss. 3, 2002-04 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite

The US back pain market will be valued at almost $23 billion in 2018, with growth driven largely by opioid receptor agonist products

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Extra billion earmarked for UK NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The billion dollar price tag of obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 620, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Sales of drugs for atrial fibrillation are projected to grow from $790 million in 2008 to $6.1 billion by 2018

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 594, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite